Evidence for IgG autoantibodies to galectin-3, a β-galactoside-binding lectin (Mac-2, ε binding protein, or carbohydrate binding protein 35) in human serum

Kenneth P. Mathews, Konstantin N. Konstantinov, Ichiro Kuwabara, Paul N. Hill, Daniel K. Hsu, Bruce L. Zuraw, Fu-Tong Liu

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Galectin-3 is a β-galactoside-binding animal lectin formerly called ε binding protein, Mac-2, carbohydrate binding protein 35, CBH 30, L-29, or L34. The possible occurrence of autoantibodies to galectin-3 was investigated because cross-linking of galectins bound to IgE or Fc εRI might produce mediator release from mast cells or basophils. Unexpectedly, a control serum from an individual free of current allergic symptoms was found to have a significantly elevated level of IgG anti-galectin-3 by ELISA employing galectin-3-coated wells incubated with test serum followed by HRPO-conjugated goat anti-human IgG; The reaction was not inhibitable by lactose, suggesting that it is not a result of binding of IgG by gaiectin-3 through lectin-carbohydrate interactions. The antibody activity was specifically adsorbed by galectin-3 and protein A-conjugated Sepharose and was associated primarily with subclass IgG1. The presence of the antibodies was confirmed by immunoblotting showing binding of IgG to the 30-kD galectin-3 band. The relevant epitopes were in the galectin-3 N-terminal domain. The propositus was subsequently found to have adenocarcinoma of the colon, and titers of IgG anti-galectin-3 were found to be sharply elevated after hemicolectomy. Similar antibody titers have not been found in family members, but small numbers of normal persons and patients with malignant neoplasms have been found to have evidence of IgG anti-galectin-3 antibodies at lower titers than the propositus. The pathogenesis of this autoimmune reaction is unclear, though there is a trend for it to occur in older persons.

Original languageEnglish (US)
Pages (from-to)329-337
Number of pages9
JournalJournal of Clinical Immunology
Volume15
Issue number6
DOIs
StatePublished - Nov 1995

Fingerprint

Galectin 2
Galectin 3
Autoantibodies
Carrier Proteins
Immunoglobulin G
Serum
Antibodies
Lectins
Galectins
Galactosides
Basophils
Lactose

Keywords

  • ε binding protein
  • autoimmunity
  • colon adenocarcinoma
  • Galectin-3
  • Mac-2

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Evidence for IgG autoantibodies to galectin-3, a β-galactoside-binding lectin (Mac-2, ε binding protein, or carbohydrate binding protein 35) in human serum. / Mathews, Kenneth P.; Konstantinov, Konstantin N.; Kuwabara, Ichiro; Hill, Paul N.; Hsu, Daniel K.; Zuraw, Bruce L.; Liu, Fu-Tong.

In: Journal of Clinical Immunology, Vol. 15, No. 6, 11.1995, p. 329-337.

Research output: Contribution to journalArticle

Mathews, Kenneth P. ; Konstantinov, Konstantin N. ; Kuwabara, Ichiro ; Hill, Paul N. ; Hsu, Daniel K. ; Zuraw, Bruce L. ; Liu, Fu-Tong. / Evidence for IgG autoantibodies to galectin-3, a β-galactoside-binding lectin (Mac-2, ε binding protein, or carbohydrate binding protein 35) in human serum. In: Journal of Clinical Immunology. 1995 ; Vol. 15, No. 6. pp. 329-337.
@article{85226742a461494fa4f7101926fff7f0,
title = "Evidence for IgG autoantibodies to galectin-3, a β-galactoside-binding lectin (Mac-2, ε binding protein, or carbohydrate binding protein 35) in human serum",
abstract = "Galectin-3 is a β-galactoside-binding animal lectin formerly called ε binding protein, Mac-2, carbohydrate binding protein 35, CBH 30, L-29, or L34. The possible occurrence of autoantibodies to galectin-3 was investigated because cross-linking of galectins bound to IgE or Fc εRI might produce mediator release from mast cells or basophils. Unexpectedly, a control serum from an individual free of current allergic symptoms was found to have a significantly elevated level of IgG anti-galectin-3 by ELISA employing galectin-3-coated wells incubated with test serum followed by HRPO-conjugated goat anti-human IgG; The reaction was not inhibitable by lactose, suggesting that it is not a result of binding of IgG by gaiectin-3 through lectin-carbohydrate interactions. The antibody activity was specifically adsorbed by galectin-3 and protein A-conjugated Sepharose and was associated primarily with subclass IgG1. The presence of the antibodies was confirmed by immunoblotting showing binding of IgG to the 30-kD galectin-3 band. The relevant epitopes were in the galectin-3 N-terminal domain. The propositus was subsequently found to have adenocarcinoma of the colon, and titers of IgG anti-galectin-3 were found to be sharply elevated after hemicolectomy. Similar antibody titers have not been found in family members, but small numbers of normal persons and patients with malignant neoplasms have been found to have evidence of IgG anti-galectin-3 antibodies at lower titers than the propositus. The pathogenesis of this autoimmune reaction is unclear, though there is a trend for it to occur in older persons.",
keywords = "ε binding protein, autoimmunity, colon adenocarcinoma, Galectin-3, Mac-2",
author = "Mathews, {Kenneth P.} and Konstantinov, {Konstantin N.} and Ichiro Kuwabara and Hill, {Paul N.} and Hsu, {Daniel K.} and Zuraw, {Bruce L.} and Fu-Tong Liu",
year = "1995",
month = "11",
doi = "10.1007/BF01541323",
language = "English (US)",
volume = "15",
pages = "329--337",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Evidence for IgG autoantibodies to galectin-3, a β-galactoside-binding lectin (Mac-2, ε binding protein, or carbohydrate binding protein 35) in human serum

AU - Mathews, Kenneth P.

AU - Konstantinov, Konstantin N.

AU - Kuwabara, Ichiro

AU - Hill, Paul N.

AU - Hsu, Daniel K.

AU - Zuraw, Bruce L.

AU - Liu, Fu-Tong

PY - 1995/11

Y1 - 1995/11

N2 - Galectin-3 is a β-galactoside-binding animal lectin formerly called ε binding protein, Mac-2, carbohydrate binding protein 35, CBH 30, L-29, or L34. The possible occurrence of autoantibodies to galectin-3 was investigated because cross-linking of galectins bound to IgE or Fc εRI might produce mediator release from mast cells or basophils. Unexpectedly, a control serum from an individual free of current allergic symptoms was found to have a significantly elevated level of IgG anti-galectin-3 by ELISA employing galectin-3-coated wells incubated with test serum followed by HRPO-conjugated goat anti-human IgG; The reaction was not inhibitable by lactose, suggesting that it is not a result of binding of IgG by gaiectin-3 through lectin-carbohydrate interactions. The antibody activity was specifically adsorbed by galectin-3 and protein A-conjugated Sepharose and was associated primarily with subclass IgG1. The presence of the antibodies was confirmed by immunoblotting showing binding of IgG to the 30-kD galectin-3 band. The relevant epitopes were in the galectin-3 N-terminal domain. The propositus was subsequently found to have adenocarcinoma of the colon, and titers of IgG anti-galectin-3 were found to be sharply elevated after hemicolectomy. Similar antibody titers have not been found in family members, but small numbers of normal persons and patients with malignant neoplasms have been found to have evidence of IgG anti-galectin-3 antibodies at lower titers than the propositus. The pathogenesis of this autoimmune reaction is unclear, though there is a trend for it to occur in older persons.

AB - Galectin-3 is a β-galactoside-binding animal lectin formerly called ε binding protein, Mac-2, carbohydrate binding protein 35, CBH 30, L-29, or L34. The possible occurrence of autoantibodies to galectin-3 was investigated because cross-linking of galectins bound to IgE or Fc εRI might produce mediator release from mast cells or basophils. Unexpectedly, a control serum from an individual free of current allergic symptoms was found to have a significantly elevated level of IgG anti-galectin-3 by ELISA employing galectin-3-coated wells incubated with test serum followed by HRPO-conjugated goat anti-human IgG; The reaction was not inhibitable by lactose, suggesting that it is not a result of binding of IgG by gaiectin-3 through lectin-carbohydrate interactions. The antibody activity was specifically adsorbed by galectin-3 and protein A-conjugated Sepharose and was associated primarily with subclass IgG1. The presence of the antibodies was confirmed by immunoblotting showing binding of IgG to the 30-kD galectin-3 band. The relevant epitopes were in the galectin-3 N-terminal domain. The propositus was subsequently found to have adenocarcinoma of the colon, and titers of IgG anti-galectin-3 were found to be sharply elevated after hemicolectomy. Similar antibody titers have not been found in family members, but small numbers of normal persons and patients with malignant neoplasms have been found to have evidence of IgG anti-galectin-3 antibodies at lower titers than the propositus. The pathogenesis of this autoimmune reaction is unclear, though there is a trend for it to occur in older persons.

KW - ε binding protein

KW - autoimmunity

KW - colon adenocarcinoma

KW - Galectin-3

KW - Mac-2

UR - http://www.scopus.com/inward/record.url?scp=0028800362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028800362&partnerID=8YFLogxK

U2 - 10.1007/BF01541323

DO - 10.1007/BF01541323

M3 - Article

C2 - 8576319

AN - SCOPUS:0028800362

VL - 15

SP - 329

EP - 337

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - 6

ER -